Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DMI Biotech is a Malaysia-based nutraceutical and preventive healthcare company focused on scientifically developed natural-herb and medicinal mushroom products. The company emphasizes cultivation and fermentation technology for Cordyceps sinensis-derived ingredients and markets food supplements aimed at wellness and immune support. Its website highlights GMP-oriented manufacturing, Japan food safety-guideline-compliant production, and collaboration with research institutions in Japan and Malaysia. DMI Biotech appears to operate as a commercial-stage wellness business rather than a drug-development biotech with a disclosed therapeutic pipeline. Its activities center on ingredient development, branded supplement products, and manufacturing rather than regulated prescription pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DMI.